全文获取类型
收费全文 | 2584篇 |
免费 | 193篇 |
国内免费 | 7篇 |
专业分类
耳鼻咽喉 | 51篇 |
儿科学 | 64篇 |
妇产科学 | 82篇 |
基础医学 | 383篇 |
口腔科学 | 59篇 |
临床医学 | 292篇 |
内科学 | 405篇 |
皮肤病学 | 159篇 |
神经病学 | 206篇 |
特种医学 | 60篇 |
外国民族医学 | 1篇 |
外科学 | 254篇 |
综合类 | 24篇 |
一般理论 | 6篇 |
预防医学 | 291篇 |
眼科学 | 32篇 |
药学 | 157篇 |
中国医学 | 1篇 |
肿瘤学 | 257篇 |
出版年
2023年 | 33篇 |
2022年 | 50篇 |
2021年 | 101篇 |
2020年 | 74篇 |
2019年 | 82篇 |
2018年 | 97篇 |
2017年 | 62篇 |
2016年 | 84篇 |
2015年 | 58篇 |
2014年 | 86篇 |
2013年 | 150篇 |
2012年 | 162篇 |
2011年 | 147篇 |
2010年 | 98篇 |
2009年 | 101篇 |
2008年 | 146篇 |
2007年 | 126篇 |
2006年 | 150篇 |
2005年 | 148篇 |
2004年 | 110篇 |
2003年 | 122篇 |
2002年 | 95篇 |
2001年 | 25篇 |
2000年 | 16篇 |
1999年 | 29篇 |
1998年 | 33篇 |
1997年 | 33篇 |
1996年 | 16篇 |
1995年 | 19篇 |
1994年 | 26篇 |
1993年 | 18篇 |
1992年 | 26篇 |
1991年 | 20篇 |
1990年 | 15篇 |
1989年 | 13篇 |
1988年 | 13篇 |
1987年 | 16篇 |
1986年 | 15篇 |
1985年 | 14篇 |
1984年 | 11篇 |
1983年 | 15篇 |
1982年 | 20篇 |
1981年 | 10篇 |
1980年 | 10篇 |
1979年 | 9篇 |
1978年 | 12篇 |
1977年 | 7篇 |
1976年 | 8篇 |
1974年 | 10篇 |
1973年 | 7篇 |
排序方式: 共有2784条查询结果,搜索用时 15 毫秒
991.
992.
993.
994.
995.
Zak M Mendonca R Balazs M Barrett K Bergeron P Blair WS Chang C Deshmukh G Devoss J Dragovich PS Eigenbrot C Ghilardi N Gibbons P Gradl S Hamman C Hanan EJ Harstad E Hewitt PR Hurley CA Jin T Johnson A Johnson T Kenny JR Koehler MF Bir Kohli P Kulagowski JJ Labadie S Liao J Liimatta M Lin Z Lupardus PJ Maxey RJ Murray JM Pulk R Rodriguez M Savage S Shia S Steffek M Ubhayakar S Ultsch M van Abbema A Ward SI Xiao L Xiao Y 《Journal of medicinal chemistry》2012,55(13):6176-6193
Herein we report the discovery of the C-2 methyl substituted imidazopyrrolopyridine series and its optimization to provide potent and orally bioavailable JAK1 inhibitors with selectivity over JAK2. The C-2 methyl substituted inhibitor 4 exhibited not only improved JAK1 potency relative to unsubstituted compound 3 but also notable JAK1 vs JAK2 selectivity (20-fold and >33-fold in biochemical and cell-based assays, respectively). Features of the X-ray structures of 4 in complex with both JAK1 and JAK2 are delineated. Efforts to improve the in vitro and in vivo ADME properties of 4 while maintaining JAK1 selectivity are described, culminating in the discovery of a highly optimized and balanced inhibitor (20). Details of the biological characterization of 20 are disclosed including JAK1 vs JAK2 selectivity levels, preclinical in vivo PK profiles, performance in an in vivo JAK1-mediated PK/PD model, and attributes of an X-ray structure in complex with JAK1. 相似文献
996.
Lurdes Tse Stephan KW Schwarz John B Bowering Randell L Moore Kyle D Burns Carole M Richford Jill A Osborn Alasdair M Barr 《Current Neuropharmacology》2012,10(3):181-196
Purpose:
The objective of this review is to evaluate the literature on medications associated with delirium after cardiac surgery and potential prophylactic agents for preventing it.Source:
Articles were searched in MEDLINE, Cumulative Index to Nursing and Allied Health, and EMBASE with the MeSH headings: delirium, cardiac surgical procedures, and risk factors, and the keywords: delirium, cardiac surgery, risk factors, and drugs. Principle inclusion criteria include having patient samples receiving cardiac procedures on cardiopulmonary bypass, and using DSM-IV-TR criteria or a standardized tool for the diagnosis of delirium.Principal Findings:
Fifteen studies were reviewed. Two single drugs (intraoperative fentanyl and ketamine), and two classes of drugs (preoperative antipsychotics and postoperative inotropes) were identified in the literature as being independently associated with delirium after cardiac surgery. Another seven classes of drugs (preoperative antihypertensives, anticholinergics, antidepressants, benzodiazepines, opioids, and statins, and postoperative opioids) and three single drugs (intraoperative diazepam, and postoperative dexmedetomidine and rivastigmine) have mixed findings. One drug (risperidone) has been shown to prevent delirium when taken immediately upon awakening from cardiac surgery. None of these findings was replicated in the studies reviewed.Conclusion:
These studies have shown that drugs taken perioperatively by cardiac surgery patients need to be considered in delirium risk management strategies. While medications with direct neurological actions are clearly important, this review has shown that specific cardiovascular drugs may also require attention. Future studies that are methodologically consistent are required to further validate these findings and improve their utility. 相似文献997.
998.
Purpose
To evaluate of the effect of size and surface characteristics of poly(isobutylcyanoacrylate) nanoparticles coated with pluronic F68 and thiolated chitosan on mucoadhesion. 相似文献999.
1000.
Duchenne muscular dystrophy (DMD) is a severe neuromuscular disorder, and one of the most frequently encountered, but one for which there is as yet no treatment. Laminin-111 protein therapy was recently shown to be a promising approach to prevent muscle disease in the mdx mouse model of DMD. The present study demonstrated that transgenic expression of laminin α1 chain in mdx animals, resulting in laminin-111 heterotrimer formation in mdx muscle, does not improve the dystrophic phenotype. The mdx mice overexpressing laminin-111 (mdxLMα1) display features of mdx littermates: dystrophic pattern of muscle biopsy, elevated creatine kinase levels, reduced muscle strength, and decreased sarcolemmal integrity. Increased expression of integrin α7 is not beneficial for mdxLMα1 muscle, and components of the dystrophin-glycoprotein complex are not restored at the sarcolemma on laminin-111 overexpression. In summary, further studies are needed to verify the functionality of laminin-111 protein therapy in DMD and to describe the molecular events resulting from this approach. 相似文献